100 related articles for article (PubMed ID: 23123424)
21. State of the art in benefit-risk analysis: economics and marketing-finance.
Kalogeras N; Odekerken-Schröder G; Pennings JM; Gunnlaugsdóttir H; Holm F; Leino O; Luteijn JM; Magnússon SH; Pohjola MV; Tijhuis MJ; Tuomisto JT; Ueland Ø; White BC; Verhagen H
Food Chem Toxicol; 2012 Jan; 50(1):56-66. PubMed ID: 21871522
[TBL] [Abstract][Full Text] [Related]
22. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
23. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
Shaller D
Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
[TBL] [Abstract][Full Text] [Related]
24. An enhanced tiered toxicity testing framework with triggers for assessing hazards and risks of commodity chemicals.
Plunkett LM; Kaplan AM; Becker RA
Regul Toxicol Pharmacol; 2010 Dec; 58(3):382-94. PubMed ID: 20709129
[TBL] [Abstract][Full Text] [Related]
25. Application of BRAFO-tiered approach for health benefit-risk assessment of dark tea consumption in China.
He M; Lyu X
Food Chem Toxicol; 2021 Dec; 158():112615. PubMed ID: 34656696
[TBL] [Abstract][Full Text] [Related]
26. A tiered approach for risk-benefit assessment of foods.
Fransen H; de Jong N; Hendriksen M; Mengelers M; Castenmiller J; Hoekstra J; van Leeuwen R; Verhagen H
Risk Anal; 2010 May; 30(5):808-16. PubMed ID: 20136741
[TBL] [Abstract][Full Text] [Related]
27. Identifying food proteins with allergenic potential: evolution of approaches to safety assessment and research to provide additional tools.
Ladics GS; Selgrade MK
Regul Toxicol Pharmacol; 2009 Aug; 54(3 Suppl):S2-6. PubMed ID: 19028539
[TBL] [Abstract][Full Text] [Related]
28. The paradox of overlapping micronutrient risks and benefits obligates risk/benefit analysis.
Verkerk RH
Toxicology; 2010 Nov; 278(1):27-38. PubMed ID: 20188138
[TBL] [Abstract][Full Text] [Related]
29. State of the art in benefit-risk analysis: introduction.
Verhagen H; Tijhuis MJ; Gunnlaugsdóttir H; Kalogeras N; Leino O; Luteijn JM; Magnússon SH; Odekerken G; Pohjola MV; Tuomisto JT; Ueland Ø; White BC; Holm F
Food Chem Toxicol; 2012 Jan; 50(1):2-4. PubMed ID: 21679738
[TBL] [Abstract][Full Text] [Related]
30. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
[TBL] [Abstract][Full Text] [Related]
31. PASSCLAIM - Synthesis and review of existing processes.
Richardson DP; Affertsholt T; Asp NG; Bruce A; Grossklaus R; Howlett J; Pannemans D; Ross R; Verhagen H; Viechtbauer V
Eur J Nutr; 2003 Mar; 42 Suppl 1():I96-111. PubMed ID: 12664324
[TBL] [Abstract][Full Text] [Related]
32. An overview of the ERICA Integrated Approach to the assessment and management of environmental risks from ionising contaminants.
Larsson CM
J Environ Radioact; 2008 Sep; 99(9):1364-70. PubMed ID: 18261830
[TBL] [Abstract][Full Text] [Related]
33. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
34. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
35. Risk assessment of carcinogens in food.
Barlow S; Schlatter J
Toxicol Appl Pharmacol; 2010 Mar; 243(2):180-90. PubMed ID: 19909764
[TBL] [Abstract][Full Text] [Related]
36. Early awareness of emerging risks associated with food and feed production: synopsis of pertinent work carried out within the SAFE FOODS project.
Marvin HJ; Kleter GA
Food Chem Toxicol; 2009 May; 47(5):911-4. PubMed ID: 19232376
[TBL] [Abstract][Full Text] [Related]
37. The identification of benefit in medical intervention: an overview and suggestions for process.
Stang PE; Pham SV; Kinchen K; Raff SB; Mussen F; Gondek K
Am J Ther; 2008; 15(5):495-503. PubMed ID: 18806527
[TBL] [Abstract][Full Text] [Related]
38. Need for an "integrated safety assessment" of GMOs, linking food safety and environmental considerations.
Haslberger AG
J Agric Food Chem; 2006 May; 54(9):3173-80. PubMed ID: 16637668
[TBL] [Abstract][Full Text] [Related]
39. A tiered system for assessing the risk of genetically modified plants to non-target organisms.
Garcia-Alonso M; Jacobs E; Raybould A; Nickson TE; Sowig P; Willekens H; Van der Kouwe P; Layton R; Amijee F; Fuentes AM; Tencalla F
Environ Biosafety Res; 2006; 5(2):57-65. PubMed ID: 17328852
[TBL] [Abstract][Full Text] [Related]
40. The application of quantitative risk assessment to microbial food safety risks.
Jaykus LA
Crit Rev Microbiol; 1996; 22(4):279-93. PubMed ID: 8989514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
